LYS-TRP-LYS-LEU-PHE-LYS-LYS-ILE-GLU-LYS-VAL-GLY-GLN-ASN-ILE-ARG-ASP-GLY-ILE-ILE-LYS-ALA-GLY-PRO-ALA-VAL-ALA-VAL-VAL-GLY-GLN-ALA-THR-GLN-ILE-ALA-LYS-NH2;LYS-TRP-LYS-LEU-PHE-LYS-LYS-ILE-GLU-LYS-VAL-GLY-GLN-ASN-ILE-ARG-ASP-GLY-ILE-ILE-LYS-ALA-GLY-PRO-ALA-VAL-ALA-VAL-VAL-GLY-GLN-ALA-THR-GLN-ILE-ALA-LYS-NH2: KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2;CECROPIN A;CECROPIN A, PORCINE;H-LYS-TRP-LYS-LEU-PHE-LYS-LYS-ILE-GLU-LYS-VAL-GLY-GLN-ASN-ILE-ARG-ASP-GLY-ILE-ILE-LYS-ALA-GLY-PRO-ALA-VAL-ALA-VAL-VAL-GLY-GLN-ALA-THR-GLN-ILE-ALA-LYS-NH2;KWKLFKKIEKVGQNIRDGIIKAGPAVAVVGQATQIAK-NH2;Cecropin A H-Lys-Trp-Lys-Leu-Phe-Lys-Lys-Ile-Glu-Lys-Val-Gly-Gln-Asn-Ile-Arg-Asp-Gly-Ile-Ile-Lys-Ala-Gly-Pro-Ala-Val-Ala-Val-Val-Gly-Gln-Ala-Thr-Gln-Ile-Ala-Lys-NH2;Cecropin A?/Cecropin A, porcine
Cecropin A is a linear 37-amino acid antimicrobial peptide with antibacterial, antitumor, and anti-inflammatory activities. It exhibits cytotoxicity against Gram-negative bacteria, including A. baumannii (strains CCARM12005, CCARM12035, CCARM12036, CCARM12037), with a minimum inhibitory concentration (MIC) of 0.5–1 μM. Cecropin A demonstrates anticancer activity by dose-dependently reducing the viability of HL-60 cells (10–50 μM), promoting ROS production, inducing mitochondrial membrane potential (Δψm) collapse, causing morphological changes in nuclear chromatin, and triggering early apoptosis and caspase-independent cell death (at 30 μM). Additionally, Cecropin A (25 μM) significantly suppresses the expression of mTNF-α, mIL-1β, and mMIP-2 mRNA and slightly inhibits mMIP-1 mRNA expression in RAW264.7 cells. It also inhibits NO production and reduces mTNF-α cytokine levels in LPS-stimulated RAW264.7 cells (0.1–5 μM), demonstrating anti-inflammatory activity.